SCHEMBL29158602

SCHEMBL29158602

N#Cc1cccc(-c2nnc(C(=O)NC3CC(CF)N(C(=O)O)C3)o2)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 2/20 0.42
▸ TNKS O95271 2/20 0.38
▸ PARP2 Q9UGN5 2/20 0.38
▸ FAAH O00519 2/20 0.36
▸ CPT2 P23786 1/20 0.35
▸ CPT1A P50416 1/20 0.35
▸ GRM5 P41594 2/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ EIF4A3 P38919 1/20 0.34
▸ NOTUM Q6P988 1/20 0.34
▸ F11 P03951 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23069429 1.00 USP30 (0.42) USP30TNKSPARP2FAAHCPT2
SCHEMBL29158597 0.90 USP30 (0.42) USP30TNKSPARP2FAAHCPT2
SCHEMBL23069407 0.90 USP30 (0.42) USP30TNKSPARP2FAAHCPT2
SCHEMBL29470213 0.89 USP30 (0.45) USP30TNKSPARP2FAAHLRRK2
SCHEMBL23069454 0.89 USP30 (0.45) USP30TNKSPARP2FAAHLRRK2
SCHEMBL23085659 0.88 USP30 (0.39) USP30TNKSPARP2CPT2CPT1A
SCHEMBL29158651 0.88 USP30 (0.39) USP30TNKSPARP2CPT2CPT1A
SCHEMBL29158658 0.88 USP30 (0.39) USP30TNKSPARP2CPT2CPT1A
SCHEMBL29770913 0.88 USP30 (0.39) USP30TNKSPARP2CPT2CPT1A
SCHEMBL23069418 0.86 USP30 (0.42) USP30TNKSPARP2FAAHGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114341133-B Substituted cyanopyrrolidines having USP30 inhibitor activity 特殊治疗有限公司 2024-02-27 — — CN disclosed
Send feedback